PDB Short entry for 1JQE HEADER TRANSFERASE 06-AUG-01 1JQE TITLE CRYSTAL STRUCTURE ANALYSIS OF HUMAN HISTAMINE METHYLTRANSFERASE TITLE 2 (ILE105 POLYMORPHIC VARIANT) COMPLEXED WITH ADOHCY AND ANTIMALARIAL TITLE 3 DRUG QUINACRINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: HISTAMINE N-METHYLTRANSFERASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: HNMT, HMT; COMPND 5 EC: 2.1.1.8; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HNMT; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: DH5A; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGEX-4T-3 KEYWDS CLASSIC METHYLTRANSFERASE FOLD, PROTEIN-SUBSTRATE-COFACTOR COMPLEX, KEYWDS 2 POLYMORPHIC VARIANT, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.R.HORTON,K.SAWADA,M.NISHIBORI,X.ZHANG,X.CHENG REVDAT 5 03-APR-24 1JQE 1 REMARK REVDAT 4 07-FEB-24 1JQE 1 REMARK SEQADV REVDAT 3 04-OCT-17 1JQE 1 REMARK REVDAT 2 24-FEB-09 1JQE 1 VERSN REVDAT 1 06-AUG-02 1JQE 0 JRNL AUTH J.R.HORTON,K.SAWADA,M.NISHIBORI,X.ZHANG,X.CHENG JRNL TITL TWO POLYMORPHIC FORMS OF HUMAN HISTAMINE METHYLTRANSFERASE: JRNL TITL 2 STRUCTURAL, THERMAL, AND KINETIC COMPARISONS. JRNL REF STRUCTURE V. 9 837 2001 JRNL REFN ISSN 0969-2126 JRNL PMID 11566133 JRNL DOI 10.1016/S0969-2126(01)00643-8 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH L.YAN,R.E.GALINSKY,J.A.BERNSTEIN,S.B.LIGGETT, REMARK 1 AUTH 2 R.M.WEINSHILBOUM REMARK 1 TITL HISTAMINE N-METHYLTRANSFERASE PHARMACOGENETICS: ASSOCIATION REMARK 1 TITL 2 OF A COMMON FUNCTIONAL POLYMORPHISM WITH ASTHMA REMARK 1 REF PHARMACOGENETICS V. 10 261 2000 REMARK 1 REFN ISSN 0960-314X REMARK 1 DOI 10.1097/00008571-200004000-00007 REMARK 1 REFERENCE 2 REMARK 1 AUTH R.M.WEINSHILBOUM,D.M.OTTERNESS,C.L.SZUMLANSKI REMARK 1 TITL METHYLATION PHARMACOGENETICS: CATECHOL O-METHYLTRANSFERASE, REMARK 1 TITL 2 THIOPURINE METHYLTRANSFERASE, AND HISTAMINE REMARK 1 TITL 3 N-METHYLTRANSFERASE REMARK 1 REF ANNU.REV.PHARMACOL.TOXICOL. V. 39 19 1999 REMARK 1 REFN ISSN 0362-1642 REMARK 1 DOI 10.1146/ANNUREV.PHARMTOX.39.1.19 REMARK 1 REFERENCE 3 REMARK 1 AUTH S.AKSOY,R.RAFTOGIANIS,R.M.WEINSHILBOUM REMARK 1 TITL HUMAN HISTAMINE N-METHYLTRANSFERASE GENE: STRUCTURAL REMARK 1 TITL 2 CHARACTERIZATION AND CHROMOSOMAL LOCATION REMARK 1 REF BIOCHEM.BIOPHYS.RES.COMMUN. V. 219 548 1996 REMARK 1 REFN ISSN 0006-291X REMARK 1 DOI 10.1006/BBRC.1996.0271 REMARK 2 REMARK 2 RESOLUTION. 1.91 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.91 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 92.1 REMARK 3 NUMBER OF REFLECTIONS : 43822 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.235 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 4412 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.91 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.94 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 39.10 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2350 REMARK 3 BIN FREE R VALUE : 0.2690 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 98 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.027 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4225 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 87 REMARK 3 SOLVENT ATOMS : 377 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 19.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.61000 REMARK 3 B22 (A**2) : 0.61000 REMARK 3 B33 (A**2) : -1.23000 REMARK 3 B12 (A**2) : 0.98000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.21 REMARK 3 ESD FROM SIGMAA (A) : 0.14 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.26 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.17 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.60 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.790 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.890 ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 RESIDUES LISTED IN REMARK 470 HAD LITTLE OR NO SIDE CHAIN DENSITY. REMARK 3 MANY RESIDUES AT N-TERMINUS HAD NO OR LITTLE VISIBLE DENSITY FOR REMARK 3 PROTEIN BACKBONE. THE DENSITY FOR THE LIGAND QUN ASSOCIATED WITH REMARK 3 CHAIN B IS NOT VERY GOOD AND IS NOT INCLUDED IN THE COORDINATES REMARK 3 SECTION. SOME DENSITIES WERE MODELLED AS WATER MOLECULES EVEN REMARK 3 THOUGH THE REFINED REMARK 3 WATER MOLECULES WERE GREATER THAN 3.5 ANGSTROMS AWAY FROM REMARK 3 MACROMOLECULE REMARK 3 ATOMS. THESE DENSITIES WERE INDEED VISIBLE AS DISCRETE "WATER REMARK 3 OXYGEN"-LIKE REMARK 3 DENSITIES BUT COULD REPRESENT MOITIES OTHER THAN WATER. REMARK 4 REMARK 4 1JQE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-AUG-01. REMARK 100 THE DEPOSITION ID IS D_1000014066. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-MAY-00 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X12C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.1000 REMARK 200 MONOCHROMATOR : SI(111) DOUBLE-CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : CUSTOM-MADE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MAR REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 202140 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.910 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.2 REMARK 200 DATA REDUNDANCY : 4.500 REMARK 200 R MERGE (I) : 0.03300 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 38.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.91 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.94 REMARK 200 COMPLETENESS FOR SHELL (%) : 43.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.21300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PARTIALLY REFINED 3.3A SEMET HNMT/ADOMET/HISTAMINE REMARK 200 STRUCTURE SOLVED BY MAD PHASING (CRYSTAL GROWN AT PH 7.5). REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.90 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 8000, SODIUM PHOSPHATE, CITRIC REMARK 280 ACID, SODIUM CHLORIDE, PH 4.2, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 6 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 -X,-Y,Z REMARK 290 5555 Y,-X+Y,Z REMARK 290 6555 X-Y,X,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 SER A 3 REMARK 465 SER A 4 REMARK 465 MET A 5 REMARK 465 ARG A 6 REMARK 465 SER A 7 REMARK 465 LEU A 8 REMARK 465 PHE A 9 REMARK 465 SER A 10 REMARK 465 ASP A 11 REMARK 465 HIS A 12 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 SER B 3 REMARK 465 SER B 4 REMARK 465 MET B 5 REMARK 465 ARG B 6 REMARK 465 SER B 7 REMARK 465 LEU B 8 REMARK 465 PHE B 9 REMARK 465 SER B 10 REMARK 465 ASP B 11 REMARK 465 HIS B 12 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 17 CG CD OE1 OE2 REMARK 470 GLU A 109 CB CG CD OE1 OE2 REMARK 470 GLU A 129 CB CG CD OE1 OE2 REMARK 470 LYS A 131 CG CD CE NZ REMARK 470 GLU A 132 CG CD OE1 OE2 REMARK 470 LEU A 133 CG CD1 CD2 REMARK 470 GLN A 192 CB CG CD OE1 NE2 REMARK 470 ASP A 194 CB CG OD1 OD2 REMARK 470 LEU A 195 CG CD1 CD2 REMARK 470 LYS A 214 CG CD CE NZ REMARK 470 THR A 253 OG1 CG2 REMARK 470 LYS A 264 CG CD CE NZ REMARK 470 GLU A 268 CG CD OE1 OE2 REMARK 470 GLU A 270 CG CD OE1 OE2 REMARK 470 LYS A 274 CG CD CE NZ REMARK 470 LYS A 275 CB CG CD CE NZ REMARK 470 GLU A 276 CB CG CD OE1 OE2 REMARK 470 LYS A 278 CG CD CE NZ REMARK 470 LYS B 14 CB CG CD CE NZ REMARK 470 TYR B 15 CB CG CD1 CD2 CE1 CE2 CZ REMARK 470 TYR B 15 OH REMARK 470 VAL B 16 CB CG1 CG2 REMARK 470 GLU B 17 CB CG CD OE1 OE2 REMARK 470 SER B 18 CB OG REMARK 470 PHE B 19 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG B 20 CB CG CD NE CZ NH1 NH2 REMARK 470 ARG B 21 CB CG CD NE CZ NH1 NH2 REMARK 470 PHE B 22 CB CG CD1 CD2 CE1 CE2 CZ REMARK 470 ASN B 24 CB CG OD1 ND2 REMARK 470 HIS B 25 CB CG ND1 CD2 CE1 NE2 REMARK 470 GLN B 30 CG CD OE1 NE2 REMARK 470 GLU B 93 CG CD OE1 OE2 REMARK 470 ASN B 107 CB CG OD1 ND2 REMARK 470 GLU B 109 CB CG CD OE1 OE2 REMARK 470 LYS B 112 CG CD CE NZ REMARK 470 LYS B 130 CB CG CD CE NZ REMARK 470 LYS B 131 CB CG CD CE NZ REMARK 470 GLU B 132 CB CG CD OE1 OE2 REMARK 470 LEU B 133 CB CG CD1 CD2 REMARK 470 LYS B 149 CG CD CE NZ REMARK 470 ARG B 189 CG CD NE CZ NH1 NH2 REMARK 470 PHE B 190 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLN B 192 CG CD OE1 NE2 REMARK 470 ASP B 193 CG OD1 OD2 REMARK 470 LYS B 214 CG CD CE NZ REMARK 470 PHE B 230 CB CG CD1 CD2 CE1 CE2 CZ REMARK 470 ASP B 232 CB CG OD1 OD2 REMARK 470 ASN B 234 CB CG OD1 ND2 REMARK 470 GLU B 235 CB CG CD OE1 OE2 REMARK 470 ASN B 236 CG OD1 ND2 REMARK 470 ASP B 238 CB CG OD1 OD2 REMARK 470 LEU B 239 CG CD1 CD2 REMARK 470 ASN B 249 CB CG OD1 ND2 REMARK 470 ASN B 251 CB CG OD1 ND2 REMARK 470 ALA B 252 CB REMARK 470 ALA B 254 CB REMARK 470 ASP B 257 CG OD1 OD2 REMARK 470 ALA B 260 CB REMARK 470 LYS B 264 CG CD CE NZ REMARK 470 LYS B 274 CG CD CE NZ REMARK 470 LYS B 275 CB CG CD CE NZ REMARK 470 GLU B 276 CB CG CD OE1 OE2 REMARK 470 LYS B 278 CB CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 193 131.27 178.21 REMARK 500 GLU B 28 -71.43 -44.58 REMARK 500 ASN B 107 -142.85 101.87 REMARK 500 LEU B 108 -124.08 65.26 REMARK 500 GLU B 109 -48.83 83.95 REMARK 500 GLU B 129 -72.88 -44.73 REMARK 500 LYS B 131 -3.09 84.98 REMARK 500 ALA B 254 132.16 -35.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 THE DENSITY FOR THE QUN MOLECULE ASSOCIATED REMARK 600 WITH MONOMER B IS NOT VERY GOOD. HOWEVER, REMARK 600 SOME DENSITY IN THIS REGION WAS MODELLED REMARK 600 AND THESE ATOMS WERE LABELLED AS RESIDUE UNX, REMARK 600 ATOM TYPE UNK. BASED ON THE QUN ASSOCIATED REMARK 600 WITH MONOMER A, ATOMS UNX 150, 151, 152, AND 376 REMARK 600 ARE WHERE THE AROMATIC RINGS OF A QUN COULD BE. REMARK 600 ATOMS UNX 133 AND 134 ARE WHERE THE AMIDE TAIL REMARK 600 OF QUN COULD BE. UNX 149 IS WHERE THE SIDE REMARK 600 CHAIN OF B TYR 15 COULD BE. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SAH A 400 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SAH B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE QUN A 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE UNX B 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE UNX B 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE UNX B 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE UNX B 405 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE UNX B 406 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE UNX B 376 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE UNX B 407 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1JQD RELATED DB: PDB REMARK 900 1JQD CONTAINS THE THR105 POLYMORPHIC VARIANT COMPLEXED WITH REMARK 900 HISTAMINE INSTEAD OF QUINACRINE DBREF 1JQE A 1 292 UNP P50135 HNMT_HUMAN 1 292 DBREF 1JQE B 1 292 UNP P50135 HNMT_HUMAN 1 292 SEQADV 1JQE ILE A 105 UNP P50135 THR 105 VARIANT SEQADV 1JQE ILE B 105 UNP P50135 THR 105 VARIANT SEQRES 1 A 292 MET ALA SER SER MET ARG SER LEU PHE SER ASP HIS GLY SEQRES 2 A 292 LYS TYR VAL GLU SER PHE ARG ARG PHE LEU ASN HIS SER SEQRES 3 A 292 THR GLU HIS GLN CYS MET GLN GLU PHE MET ASP LYS LYS SEQRES 4 A 292 LEU PRO GLY ILE ILE GLY ARG ILE GLY ASP THR LYS SER SEQRES 5 A 292 GLU ILE LYS ILE LEU SER ILE GLY GLY GLY ALA GLY GLU SEQRES 6 A 292 ILE ASP LEU GLN ILE LEU SER LYS VAL GLN ALA GLN TYR SEQRES 7 A 292 PRO GLY VAL CYS ILE ASN ASN GLU VAL VAL GLU PRO SER SEQRES 8 A 292 ALA GLU GLN ILE ALA LYS TYR LYS GLU LEU VAL ALA LYS SEQRES 9 A 292 ILE SER ASN LEU GLU ASN VAL LYS PHE ALA TRP HIS LYS SEQRES 10 A 292 GLU THR SER SER GLU TYR GLN SER ARG MET LEU GLU LYS SEQRES 11 A 292 LYS GLU LEU GLN LYS TRP ASP PHE ILE HIS MET ILE GLN SEQRES 12 A 292 MET LEU TYR TYR VAL LYS ASP ILE PRO ALA THR LEU LYS SEQRES 13 A 292 PHE PHE HIS SER LEU LEU GLY THR ASN ALA LYS MET LEU SEQRES 14 A 292 ILE ILE VAL VAL SER GLY SER SER GLY TRP ASP LYS LEU SEQRES 15 A 292 TRP LYS LYS TYR GLY SER ARG PHE PRO GLN ASP ASP LEU SEQRES 16 A 292 CYS GLN TYR ILE THR SER ASP ASP LEU THR GLN MET LEU SEQRES 17 A 292 ASP ASN LEU GLY LEU LYS TYR GLU CYS TYR ASP LEU LEU SEQRES 18 A 292 SER THR MET ASP ILE SER ASP CYS PHE ILE ASP GLY ASN SEQRES 19 A 292 GLU ASN GLY ASP LEU LEU TRP ASP PHE LEU THR GLU THR SEQRES 20 A 292 CYS ASN PHE ASN ALA THR ALA PRO PRO ASP LEU ARG ALA SEQRES 21 A 292 GLU LEU GLY LYS ASP LEU GLN GLU PRO GLU PHE SER ALA SEQRES 22 A 292 LYS LYS GLU GLY LYS VAL LEU PHE ASN ASN THR LEU SER SEQRES 23 A 292 PHE ILE VAL ILE GLU ALA SEQRES 1 B 292 MET ALA SER SER MET ARG SER LEU PHE SER ASP HIS GLY SEQRES 2 B 292 LYS TYR VAL GLU SER PHE ARG ARG PHE LEU ASN HIS SER SEQRES 3 B 292 THR GLU HIS GLN CYS MET GLN GLU PHE MET ASP LYS LYS SEQRES 4 B 292 LEU PRO GLY ILE ILE GLY ARG ILE GLY ASP THR LYS SER SEQRES 5 B 292 GLU ILE LYS ILE LEU SER ILE GLY GLY GLY ALA GLY GLU SEQRES 6 B 292 ILE ASP LEU GLN ILE LEU SER LYS VAL GLN ALA GLN TYR SEQRES 7 B 292 PRO GLY VAL CYS ILE ASN ASN GLU VAL VAL GLU PRO SER SEQRES 8 B 292 ALA GLU GLN ILE ALA LYS TYR LYS GLU LEU VAL ALA LYS SEQRES 9 B 292 ILE SER ASN LEU GLU ASN VAL LYS PHE ALA TRP HIS LYS SEQRES 10 B 292 GLU THR SER SER GLU TYR GLN SER ARG MET LEU GLU LYS SEQRES 11 B 292 LYS GLU LEU GLN LYS TRP ASP PHE ILE HIS MET ILE GLN SEQRES 12 B 292 MET LEU TYR TYR VAL LYS ASP ILE PRO ALA THR LEU LYS SEQRES 13 B 292 PHE PHE HIS SER LEU LEU GLY THR ASN ALA LYS MET LEU SEQRES 14 B 292 ILE ILE VAL VAL SER GLY SER SER GLY TRP ASP LYS LEU SEQRES 15 B 292 TRP LYS LYS TYR GLY SER ARG PHE PRO GLN ASP ASP LEU SEQRES 16 B 292 CYS GLN TYR ILE THR SER ASP ASP LEU THR GLN MET LEU SEQRES 17 B 292 ASP ASN LEU GLY LEU LYS TYR GLU CYS TYR ASP LEU LEU SEQRES 18 B 292 SER THR MET ASP ILE SER ASP CYS PHE ILE ASP GLY ASN SEQRES 19 B 292 GLU ASN GLY ASP LEU LEU TRP ASP PHE LEU THR GLU THR SEQRES 20 B 292 CYS ASN PHE ASN ALA THR ALA PRO PRO ASP LEU ARG ALA SEQRES 21 B 292 GLU LEU GLY LYS ASP LEU GLN GLU PRO GLU PHE SER ALA SEQRES 22 B 292 LYS LYS GLU GLY LYS VAL LEU PHE ASN ASN THR LEU SER SEQRES 23 B 292 PHE ILE VAL ILE GLU ALA HET SAH A 400 26 HET QUN A 500 28 HET SAH B 401 26 HET UNX B 402 1 HET UNX B 403 1 HET UNX B 404 1 HET UNX B 405 1 HET UNX B 406 1 HET UNX B 376 1 HET UNX B 407 1 HETNAM SAH S-ADENOSYL-L-HOMOCYSTEINE HETNAM QUN QUINACRINE HETNAM UNX UNKNOWN ATOM OR ION HETSYN QUN 6-CHLORO-9-[[4-(DIETHYLAMINO)-1-METHYLBUTYL]AMINO]-2- HETSYN 2 QUN METHOXYACRIDINE FORMUL 3 SAH 2(C14 H20 N6 O5 S) FORMUL 4 QUN C23 H30 CL N3 O FORMUL 6 UNX 7(X) FORMUL 13 HOH *377(H2 O) HELIX 1 1 GLY A 13 HIS A 25 1 13 HELIX 2 2 THR A 27 LYS A 39 1 13 HELIX 3 3 LYS A 39 ILE A 44 1 6 HELIX 4 4 GLY A 64 TYR A 78 1 15 HELIX 5 5 SER A 91 ALA A 103 1 13 HELIX 6 6 THR A 119 LEU A 128 1 10 HELIX 7 7 MET A 144 VAL A 148 5 5 HELIX 8 8 ASP A 150 LEU A 161 1 12 HELIX 9 9 SER A 177 GLY A 187 1 11 HELIX 10 10 SER A 188 PHE A 190 5 3 HELIX 11 11 THR A 200 GLY A 212 1 13 HELIX 12 12 SER A 227 ILE A 231 5 5 HELIX 13 13 ASN A 234 GLU A 246 1 13 HELIX 14 14 ASN A 249 ALA A 254 1 6 HELIX 15 15 PRO A 255 LEU A 266 1 12 HELIX 16 16 GLY B 13 ASN B 24 1 12 HELIX 17 17 THR B 27 LYS B 39 1 13 HELIX 18 18 LYS B 39 GLY B 45 1 7 HELIX 19 19 GLY B 64 TYR B 78 1 15 HELIX 20 20 SER B 91 ILE B 105 1 15 HELIX 21 21 THR B 119 GLU B 129 1 11 HELIX 22 22 MET B 144 VAL B 148 5 5 HELIX 23 23 ASP B 150 LEU B 161 1 12 HELIX 24 24 SER B 177 GLY B 187 1 11 HELIX 25 25 THR B 200 GLY B 212 1 13 HELIX 26 26 SER B 227 ILE B 231 5 5 HELIX 27 27 ASN B 234 GLU B 246 1 13 HELIX 28 28 ASN B 249 ALA B 254 1 6 HELIX 29 29 PRO B 255 LEU B 266 1 12 SHEET 1 A 7 VAL A 111 HIS A 116 0 SHEET 2 A 7 CYS A 82 VAL A 88 1 N ILE A 83 O LYS A 112 SHEET 3 A 7 GLU A 53 ILE A 59 1 N ILE A 56 O ASN A 84 SHEET 4 A 7 TRP A 136 ILE A 142 1 O PHE A 138 N LEU A 57 SHEET 5 A 7 LEU A 162 VAL A 173 1 O GLY A 163 N TRP A 136 SHEET 6 A 7 LEU A 285 GLU A 291 -1 O ILE A 290 N MET A 168 SHEET 7 A 7 TYR A 215 LEU A 220 -1 N TYR A 218 O PHE A 287 SHEET 1 B 3 THR A 223 ASP A 225 0 SHEET 2 B 3 LYS A 278 ASN A 282 -1 O PHE A 281 N MET A 224 SHEET 3 B 3 SER A 272 LYS A 275 -1 N ALA A 273 O LEU A 280 SHEET 1 C 7 VAL B 111 HIS B 116 0 SHEET 2 C 7 CYS B 82 VAL B 88 1 N VAL B 87 O HIS B 116 SHEET 3 C 7 GLU B 53 ILE B 59 1 N SER B 58 O VAL B 88 SHEET 4 C 7 TRP B 136 ILE B 142 1 O PHE B 138 N LEU B 57 SHEET 5 C 7 LEU B 162 VAL B 173 1 O GLY B 163 N TRP B 136 SHEET 6 C 7 LEU B 285 GLU B 291 -1 O ILE B 288 N ILE B 170 SHEET 7 C 7 TYR B 215 LEU B 220 -1 N TYR B 218 O PHE B 287 SHEET 1 D 3 THR B 223 ASP B 225 0 SHEET 2 D 3 LYS B 278 ASN B 282 -1 O PHE B 281 N MET B 224 SHEET 3 D 3 SER B 272 LYS B 275 -1 N LYS B 275 O LYS B 278 SITE 1 AC1 22 PHE A 19 HIS A 29 GLY A 60 GLY A 62 SITE 2 AC1 22 GLU A 89 PRO A 90 SER A 91 GLN A 94 SITE 3 AC1 22 THR A 119 SER A 120 ILE A 142 GLN A 143 SITE 4 AC1 22 MET A 144 TYR A 147 QUN A 500 HOH A 533 SITE 5 AC1 22 HOH A 719 HOH A 720 HOH A 721 HOH A 722 SITE 6 AC1 22 HOH A 723 HOH A 724 SITE 1 AC2 17 HIS B 29 GLY B 60 GLY B 62 ILE B 66 SITE 2 AC2 17 GLU B 89 PRO B 90 SER B 91 GLN B 94 SITE 3 AC2 17 THR B 119 SER B 120 ILE B 142 GLN B 143 SITE 4 AC2 17 MET B 144 TYR B 147 HOH B 556 HOH B 557 SITE 5 AC2 17 HOH B 558 SITE 1 AC3 14 TYR A 15 VAL A 16 TYR A 146 TYR A 147 SITE 2 AC3 14 TRP A 179 TRP A 183 ASP A 193 LEU A 195 SITE 3 AC3 14 CYS A 196 PHE A 243 GLU A 246 SAH A 400 SITE 4 AC3 14 HOH A 725 HOH A 726 SITE 1 AC4 1 UNX B 403 SITE 1 AC5 1 UNX B 402 SITE 1 AC6 2 UNX B 376 UNX B 405 SITE 1 AC7 2 UNX B 404 UNX B 406 SITE 1 AC8 2 UNX B 405 UNX B 407 SITE 1 AC9 1 UNX B 404 SITE 1 BC1 1 UNX B 406 CRYST1 130.340 130.340 63.010 90.00 90.00 120.00 P 6 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007672 0.004429 0.000000 0.00000 SCALE2 0.000000 0.008859 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015870 0.00000